Pharmacokinetics in Drug Development Volume 2 details the key regulatory and development paradigms in which pharmacokinetic supplements decision-making during drug development.
Contents
Part 1: Drug Development and Regulatory Issues
- Drug Development: A Rational Approach
- Experimental Design Considerations in Pharmacokinetic Studies
- Exposure-Response Relationships: A Critical Review of the FDA Guidance and Its Practical Utility
- Role fo Toxicology and Toxicokinetics in Drug Development
- Bioanaysis in a Regulated Environment
- Role of Preclinical Pharmacokinetics in Drug Development
- Pharmacokinetics/Pharmacodynamic Knowledge Discovery and Creation During Drug Development
- Regulatory Aspects of Clinical Pharmacokinetic Studies
- Regulatory Review of Pharmacokinetic Studies
- Regulatory Perspectives on Clinical Trial Simulations
- Nuances of Drug Metabolism and Pharmacokinetic Requirements for Package Submission to Japanese Regulatory Authorities
Part 2: Special Topics
- Drug Development in Oncology
- Development of Chiral Compounds
- Development of Controlled-release Products
- Development Considerations for Biological Drugs
- Pharmacokinetics is Ocular Drug Development
- Development of Parenteral Dosage Forms
- Development of Transdermal Products
Index
Also available:
Volume 1: Clinical Study Design and Analysis